公开(公告)号：IL311965A

公开(公告)日：2024-06-01

申请号：IL31196524

申请日：2024-04-07

Applicant: DEKA PRODUCTS LP ,  ANDREWS RICHARD E ,  BIBEAU TRAVIS G ,  BOWDEN SCOTT R ,  BRADLEY MARGARET B ,  CANNAN DAVID D B ,  GLOEB MCDONALD ROBERT G ,  JACOBSON STUART A ,  JOHNSON HANS E ,  LOPRIORE DOMINIC P ,  MOREAU TIMOTHY D ,  NAEEM ALDEN S ,  NARO TREVOR M ,  NORRIS MATTHEW A ,  REMEC ANDREW G ,  SIMM DAVID A ,  VIOLETTE KEITH D

Inventor： ANDREWS RICHARD E ,  BIBEAU TRAVIS G ,  BOWDEN SCOTT R ,  BRADLEY MARGARET B ,  CANNAN DAVID D B ,  GLOEB-MCDONALD ROBERT G ,  JACOBSON STUART A ,  JOHNSON HANS E ,  LOPRIORE DOMINIC P ,  MOREAU TIMOTHY D ,  NAEEM ALDEN S ,  NARO TREVOR M ,  NORRIS MATTHEW A ,  REMEC ANDREW G ,  SIMM DAVID A ,  VIOLETTE KEITH D

IPC: F16H25/20

Abstract: A system and method to enable treatment through cell therapy. The system can enable cell injection such as, for example, injecting beta cells/islets, cartilage cells, fat cells, and others. The system and method ensure that the delivery rate and delivered volume of the material pumped through a tube and into the injection needle is consistent over the course of the start-operation-stop process from run to run. The system and method can automatically stop delivery and alarm if an occlusion is detected during delivery.

公开(公告)号：CA3234138A1

公开(公告)日：2023-04-13

申请号：CA3234138

申请日：2022-10-06

Applicant: DEKA PRODUCTS LP

Inventor： JOHNSON HANS E ,  REMEC ANDREW G ,  CANNAN DAVID D B ,  VIOLETTE KEITH D ,  NORRIS MATTHEW A ,  MOREAU TIMOTHY D ,  BIBEAU TRAVIS G ,  BRADLEY MARGARET B ,  JACOBSON STUART A ,  GLOEB-MCDONALD ROBERT G ,  BOWDEN SCOTT R ,  ANDREWS RICHARD E ,  LOPRIORE DOMINIC P ,  NAEEM ALDEN S ,  NARO TREVOR M ,  SIMM DAVID A

Abstract: A system and method to enable treatment through cell therapy. The system can enable cell injection such as, for example, injecting beta cells/islets, cartilage cells, fat cells, and others. The system and method ensure that the delivery rate and delivered volume of the material pumped through a tube and into the injection needle is consistent over the course of the start-operation-stop process from run to run. The system and method can automatically stop delivery and alarm if an occlusion is detected during delivery.

公开(公告)号：MX2024004298A

公开(公告)日：2024-06-28

申请号：MX2024004298

申请日：2022-10-06

Applicant: DEKA PRODUCTS LP

Inventor： NORRIS MATTHEW A ,  CANNAN DAVID D B ,  MOREAU TIMOTHY D ,  NARO TREVOR M ,  BIBEAU TRAVIS G ,  JOHNSON HANS E ,  JACOBSON STUART A ,  BRADLEY MARGARET B ,  REMEC ANDREW G ,  VIOLETTE KEITH D ,  GLOEB-MCDONALD ROBERT G ,  BOWDEN SCOTT R ,  ANDREWS RICHARD E ,  LOPRIORE DOMINIC P ,  NAEEM ALDEN S ,  SIMM DAVID A

IPC: A61M5/315 ,  A61M5/00 ,  A61M5/20 ,  A61M5/31 ,  A61M5/48 ,  F16H25/20

Abstract: Un sistema y método para permitir el tratamiento a través de terapia celular; el sistema puede permitir la inyección de células, tales como, por ejemplo, inyectar células beta/islotes, células de cartílago, células de grasa y otras; el sistema y método aseguran que la velocidad de distribución y el volumen distribuido del material bombeado a través de un tubo y hacia dentro de la aguja de inyección es consistente sobre el curso del proceso inicio-operación-paro de corrida a corrida; el sistema y el método pueden parar automáticamente la distribución y alarma si se detecta un bloqueo durante la distribución.

公开(公告)号：AU2022360373A1

公开(公告)日：2024-05-02

申请号：AU2022360373

申请日：2022-10-06

Applicant: DEKA PRODUCTS LP

Inventor： JOHNSON HANS E ,  REMEC ANDREW G ,  CANNAN DAVID D B ,  VIOLETTE KEITH D ,  NORRIS MATTHEW A ,  MOREAU TIMOTHY D ,  BIBEAU TRAVIS G ,  BRADLEY MARGARET B ,  JACOBSON STUART A ,  GLOEB-MCDONALD ROBERT G ,  BOWDEN SCOTT R ,  ANDREWS RICHARD E ,  LOPRIORE DOMINIC P ,  NAEEM ALDEN S ,  NARO TREVOR M ,  SIMM DAVID A

IPC: A61M5/315 ,  A61M5/48 ,  F16H25/20

Abstract: A system and method to enable treatment through cell therapy. The system can enable cell injection such as, for example, injecting beta cells/islets, cartilage cells, fat cells, and others. The system and method ensure that the delivery rate and delivered volume of the material pumped through a tube and into the injection needle is consistent over the course of the start-operation-stop process from run to run. The system and method can automatically stop delivery and alarm if an occlusion is detected during delivery.